Table 1 Clinicopathological features of the 144 breast tumour specimens included in this study
deceased patients | 5 year survivors | lack 5 years follow-up | Total | |
|---|---|---|---|---|
Median age at diagnosis | 77 | 63 | 75 | 65 |
Recurrence free for 5 years | ||||
yes | 0 | 102 | 0 | 102 |
no | 16 | 7 | 1 | 24 |
missing | 16 | 2 | 0 | 18 |
Total | 32 | 111 | 1 | 144 |
Type | ||||
ductal | 26 | 77 | 1 | 104 |
lobular | 4 | 23 | 0 | 27 |
tubular | 1 | 6 | 0 | 7 |
medullary | 1 | 2 | 0 | 3 |
missing | 0 | 3 | 0 | 3 |
Total | 32 | 111 | 1 | 144 |
Size | ||||
median (mm) | 27 | 19 | 27 | 20 |
20 mm and below | 11 | 62 | 0 | 73 |
above 20 mm | 21 | 49 | 1 | 71 |
Total | 32 | 111 | 1 | 144 |
Nodal status | ||||
positive | 17 | 38 | 1 | 56 |
negative | 10 | 63 | 0 | 73 |
missing | 5 | 10 | 0 | 15 |
Total | 32 | 111 | 1 | 144 |
Estrogen receptor status | ||||
positive | 23 | 101 | 1 | 125 |
negative | 9 | 10 | 0 | 19 |
Total | 32 | 111 | 1 | 144 |
Progesterone receptor status | ||||
positive | 15 | 85 | 0 | 100 |
negative | 17 | 26 | 1 | 44 |
Total | 32 | 111 | 1 | 144 |
Her2 status | ||||
positive | 7 | 6 | 0 | 13 |
negative | 22 | 101 | 0 | 123 |
missing | 3 | 4 | 1 | 8 |
Total | 32 | 111 | 1 | 144 |